X

Trial Profile

Evaluation of the Adherence and the Patient Acceptability of Zomacton Treatment With the Zomajet Vision X Device

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Somatropin (Primary)
Indications Somatotropin deficiency; Turner's syndrome
Focus Therapeutic Use
Acronyms ZOMAXEPT
Sponsors Ferring Pharmaceuticals

Most Recent Events

11 May 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrial.gov.
18 Nov 2014 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018 as reported by ClinicalTrial.gov record.
16 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com